Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

Yun‐Fan Liaw, Joseph J.�Y. Sung, Wan Cheng Chow et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +16

Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡

Ting‐Tsung Chang, Yun‐Fan Liaw, Shun-Sheng Wu et al. · Hepatology · 2010 · 988 citations · Full text

Medicine, Pathology, Pharmacotherapy +17

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

E. Jenny Heathcote, Patrick Marcellin, Edward Gane et al. · Gastroenterology · 2010 · 461 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Gi‐Ae Kim, Young‐Suk Lim, Jihyun An et al. · Gut · 2013 · 418 citations

Pharmacy, Pharmacology, Pharmacotherapy +16